UPDATE: Novogen Announces Cantrixil Receives Orphan Drug Designation from FDA for Ovarian Cancer
April 21, 2015 at 21:37 PM EDT
US-Australian drug discovery company, Novogen (NASDAQ: NVGN), today announced that its subsidiary joint venture company with Yale ...